What question did this study set out to answer?

This research aims to compare clinical and pathologic features of breast cancer patients with and without BRCA mutations.

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer

View Full Paper

Ask AI

Bookmark

Authors

Retrospective review examines tumor and clinical characteristics of BRCA mutation carriers, suggesting treatment implications.

This research aims to compare clinical and pathologic features of breast cancer patients with and without BRCA mutations.
Examined 491 breast cancer patients who underwent BRCA mutation testing from 1997 to 2006.
Conducted a retrospective review of medical records for clinical features and tumor pathology.
Analyzed characteristics such as age at diagnosis, number of pregnancies, and hormone receptor status.
57.1% of BRCA1-positive patients had triple-negative breast cancer compared to 23.3% of BRCA2-positive and 13.8% of BRCA-negative patients.
BRCA1 mutation carriers had higher nuclear grade tumors (P < .001).
BRCA2 mutation carriers were older at diagnosis than both BRCA1 carriers and non-carriers (P < .01).

Atchley et al. (2008) studied this question.

View Full Paper

Ask AI

Bookmark